Table 1 Multivariate analysis evaluating the role of patient and pathological factors on the BRCA1- 3’UTR-variant positivity
From: A germline mutation in the BRCA13’UTR predicts Stage IV breast cancer
Multivariate analysis | p-value | OR | 95% CI | |
|---|---|---|---|---|
Age | 0.915 | 1 | 0.98-1.02 | |
Menopausal status: | Post | 0.492 | 1.29 | 0.62-2.69 |
Grade | 2 | 0.493 | 0.83 | 0.49-1.41 |
3 | 0.145 | 0.66 | 0.38-1.16 | |
Stage | 2 | 0.065 | 1.48 | 0.98-2.24 |
3 | 0.169 | 1.41 | 0.87-2.29 | |
4 | 0.018 | 3.73 | 1.26-11.07 | |
ER and/or PR status: | Positive | 0.603 | 0.88 | 0.56-1.41 |